[The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines]
- PMID: 2117320
[The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines]
Abstract
The preparation of low-molecular protective antigen (PA) isolated from strain 34F2 (Sterne) and having a molecular weight of 34 and 51 kD, unlike the preparation of high-molecular PA with a molecular weight of 87 kD, suppressed the formation of acquired resistance to anthrax when introduced into guinea pigs in mixture with live spores of strains of STI, 34F2 and new vaccine strain 228/8; this phenomenon was mainly accompanied by a decrease in the level of antibodies to lethal factor (LF) nad in the antitoxic activity of blood serum. The immunosuppressing action of low-molecular PA depended on the kind of vaccine strain introduced together with this antigen, which suggested the existence of differences in the ligand determinants of strains 34F2 and STI. In contrast to high-molecular PA, low-molecular PA blocked the action of the lethal mixture of PA and LF on the culture of peritoneal mononuclear phagocytes of CBA mice. The competitive relationships between low-molecular PA and high-molecular PA are discussed.
Similar articles
-
Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.Infect Immun. 1990 Feb;58(2):303-8. doi: 10.1128/iai.58.2.303-308.1990. Infect Immun. 1990. PMID: 2105269 Free PMC article.
-
[The assessment of antitoxic anti-anthrax immunity].Zh Mikrobiol Epidemiol Immunobiol. 1990 Dec;(12):78-82. Zh Mikrobiol Epidemiol Immunobiol. 1990. PMID: 2129149 Russian.
-
A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.Vaccine. 2017 Oct 20;35(44):6030-6040. doi: 10.1016/j.vaccine.2017.03.033. Epub 2017 Mar 23. Vaccine. 2017. PMID: 28342664
-
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14. Infect Immun. 2007. PMID: 17502384 Free PMC article.
-
Progress and novel strategies in vaccine development and treatment of anthrax.Immunol Rev. 2011 Jan;239(1):221-36. doi: 10.1111/j.1600-065X.2010.00969.x. Immunol Rev. 2011. PMID: 21198675 Review.
Cited by
-
Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.Infect Immun. 1999 Feb;67(2):562-7. doi: 10.1128/IAI.67.2.562-567.1999. Infect Immun. 1999. PMID: 9916059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources